This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Nexus Chile’s acquisition of Isapre Colmena Salud rejected by the Chilean competition authority

( February 3, 2022, 20:15 GMT | Official Statement) -- MLex Summary: Nexus Chile SpA’s planned acquisition of Isapre Colmena Salud S.A. was rejected by the Chilean competition authority, according to a statement. After an in-depth review of the deal, the Fiscalía Nacional Económica, or FNE, concluded that the transaction would “substantially reduce competition” in the Chilean health insurance market, leading to higher costs and worse medical coverage for consumers.FNE statement follows below in Spanish:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections